Skip to main navigation
Skip to search
Skip to main content
Montclair State University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Grants/Projects
Research output
Prizes
Press/Media
Search by expertise, name or affiliation
Phosphodiesterase 5 inhibitors: Current status and potential applications
David P. Rotella
Chemistry and Biochemistry
Research output
:
Contribution to journal
›
Review article
›
peer-review
283
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phosphodiesterase 5 inhibitors: Current status and potential applications'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Phosphodiesterase Type 5 Inhibitors
100%
Erectile Dysfunction
20%
Phosphodiesterase
20%
Medicinal Chemistry
20%
Cyclic Adenosine Monophosphate (cAMP)
20%
Therapeutic Potential
20%
Clinical Trials
20%
Clinical Experience
20%
Nucleotide Monophosphate
20%
Cyclic GMP-AMP
20%
Sildenafil
20%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphodiesterase V Inhibitor
100%
Phosphodiesterase V
25%
Phosphodiesterase
25%
Erectile Dysfunction
25%
Pharmaceutical Chemistry
25%
Clinical Trial
25%
Sildenafil
25%
Cyclic AMP
25%
Cyclic GMP
25%